For research use only. Not for therapeutic Use.
3,4-<wbr></wbr>Methylenedioxyamphetamine (MDA) is psychedelic and entactogenic drug that is scheduled as a controlled substance in the United States. N-<wbr></wbr>hydroxy-<wbr></wbr>MDA is an analog of MDA (Item No. <span class=/itemid/>11554</span>, hydrochloride form) which inhibits reuptake of noradrenaline (IC<sub>50</sub> = 87.8 μM) more effectively than serotonin (IC<sub>50</sub> = 215 μM). Like MDA, N-<wbr></wbr>hydroxy-<wbr></wbr>MDA is regulated in the United States. This product is intended for forensic and research applications.
| Catalog Number | R064572 |
| CAS Number | 74341-83-6 |
| Synonyms | MDOH;N-hydroxy-3,4-Methylenedioxyamphetamine |
| Molecular Formula | C10H14ClNO3 |
| Purity | ≥95% |
| Storage | -20°C |
| IUPAC Name | N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]hydroxylamine;hydrochloride |
| InChI | InChI=1S/C10H13NO3.ClH/c1-7(11-12)4-8-2-3-9-10(5-8)14-6-13-9;/h2-3,5,7,11-12H,4,6H2,1H3;1H |
| InChIKey | DMBCJQVFXIKFJX-UHFFFAOYSA-N |
| SMILES | CC(CC1=CC2=C(C=C1)OCO2)NO.Cl |
| Reference | 1.Baggott, M.J.,Siegrist, J.D.,Galloway, G.P., et al. Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): A randomized controlled trial in humans. PLoS One 5(12), 1-13 (2010). |
